Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein - PubMed (original) (raw)
Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein
Kentaro Murakami et al. Transl Stroke Res. 2011.
Abstract
Subarachnoid hemorrhage (SAH) following cerebral aneurysm rupture is associated with high rates of morbidity and mortality. Surviving SAH patients often suffer from neurological impairment, yet little is currently known regarding the influence of subarachnoid blood on brain parenchyma. The objective of the present study was to examine the impact of subarachnoid blood on glial cells using a rabbit SAH model. The astrocyte-specific proteins, glial fibrillary acidic protein (GFAP) and S100B, were up-regulated in brainstem from SAH model rabbits, consistent with the development of reactive astrogliosis. In addition to reactive astrogliosis, cytosolic expression of the pro-inflammatory cytokine, high-mobility group box 1 protein (HMGB1) was increased in brain from SAH animals. We found that greater than 90% of cells expressing cytosolic HMGB1 immunostained positively for Iba1, a specific marker for microglia and macrophages. Further, the number of Iba1-positive cells was similar in brain from control and SAH animals, suggesting the majority of these cells were likely resident microglial cells rather than infiltrating macrophages. These observations demonstrate SAH impacts brain parenchyma by activating astrocytes and microglia, triggering up-regulation of the pro-inflammatory cytokine HMGB1.
Conflict of interest statement
Disclosure The authors declare no conflicts of interest.
Figures
Fig. 1
Distribution of blood following experimental SAH in rabbits. Ventral view of brains obtained from a healthy control (left panel) and a 5-day SAH animal (right panel). Brainstem tissue, used throughout this study, was obtained 1–2 mm below the brain surface from regions denoted by black rectangular boxes
Fig. 2
Enhanced expression of glial fibrillary acidic protein (GFAP) in brainstem from SAH model animals. a GFAP immunostaining is increased in brainstem from SAH model animals. Images demonstrate enhanced GFAP immunostaining in brainstem obtained from a 5-day SAH animal. Bar graph expresses GFAP immunostaining, in arbitrary density units (ADU), in tissue obtained from un-operated control (_n_= 6), 5-day sham-operated (_n_=4), 2-day SAH (_n_=4), and 5-day SAH (n_=6) animals. Three images per animal were randomly selected for analysis. Scale bar: 50 μm. **p<0.01 versus control and §§_p<0.01 versus sham using Tukey–Kramer multiple comparison test. b GFAP protein is increased in brainstem following SAH. Western blot demonstrating immunoreactive bands corresponding to GFAP and β-tubulin using 5 μg of protein obtained from control (_n_=4), sham-operated (_n_=3), 2-day SAH (n_=4), and 5-day SAH (n_=3) brainstem. GFAP band intensity was quantified using NIH software (ImageJ) and expressed as a ratio to β-tubulin band intensity. **p<0.01, *p<0.05, versus control and §§_p<0.01, §_p<0.05 versus sham using Tukey–Kramer multiple comparison test
Fig. 3
Enhanced expression of S100B and HMGB1 in brainstem from SAH rabbits. a Top panel representative image of an RT–PCR gel using S100B- and GAPDH-specific primers. Bottom panel summarized RT–PCR data obtained from RNA isolated from brainstem of control (_n_=5), sham-operated (_n_=5), 2-day SAH (_n_=6), and 5-day SAH (_n_=6) animals using quantitative densitometric analysis. S100B band intensity is expressed relative to GAPDH band intensity for each animal. b Top panel representative image of an RT–PCR gel using HMGB1-specific primers. Bottom panel quantification of HMGB1 mRNA in brainstem from control (_n_=5), sham-operated (_n_=5), 2-day (_n_=4), and 5-day SAH (_n_=5) animals. Data were obtained using quantitative densitometric analysis of RT–PCR gels. HMGB1 band intensity is expressed relative to GAPDH band intensity for each animal. c Top panel Western blot demonstrating immunoreactive bands corresponding to HMGB1 using 5 μg of protein obtained from control, sham-operated, 2-day SAH, and 5-day SAH brainstem. Bottom panel quantification of HMGB1 protein levels in brainstem from control (_n_=4), sham-operated (_n_=3), 2-day (_n_=4), and 5-day SAH (n_=3) animals obtained using Western blot. HMGB1 band intensity was quantified using NIH software (ImageJ) and expressed as a ratio to β-tubulin band intensity. *p<0.05 versus control and §_p<0.05 versus sham using Tukey–Kramer multiple comparison test
Fig. 4
Cytosolic expression of HMGB1 in Iba1-positive cells of brainstem from SAH animals. a, b HMGB1 immunostaining images obtained from brainstem of a control (a) and a 5-day SAH (b) animal. c, d Merged images of HMGB1 immunos-taining (green) and DAPI nuclear staining (blue). e, f Merged images of HMGB1 immunostaining (green) and Iba1 immunostaining (red). Enlarged images on the right side of each panel highlight the increased number of Iba1-positive cells with cytosolic staining of HMGB1 in brainstem from SAH animals. Scale bars represent 5 μm. g Quantification of the density of cells staining positively for Iba1 and cytosolic HMGB1. Values were obtained from averaging three to four brainstem images per animal (_n_=4 animals per group). **p<0.01, Student t test
Similar articles
- Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage.
Li H, Wu W, Sun Q, Liu M, Li W, Zhang XS, Zhou ML, Hang CH. Li H, et al. Brain Res. 2014 Jan 16;1543:315-23. doi: 10.1016/j.brainres.2013.11.023. Epub 2013 Nov 26. Brain Res. 2014. PMID: 24291745 - Glycyrrhizic acid confers neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of subarachnoid hemorrhage.
Sun Q, Wang F, Li W, Li W, Hu YC, Li S, Zhu JH, Zhou M, Hang CH. Sun Q, et al. Med Hypotheses. 2013 Oct;81(4):681-5. doi: 10.1016/j.mehy.2013.07.026. Epub 2013 Aug 7. Med Hypotheses. 2013. PMID: 23932051 - Anti-high mobility group box-1 antibody attenuated vascular smooth muscle cell phenotypic switching and vascular remodelling after subarachnoid haemorrhage in rats.
Wang L, Zhang Z, Liang L, Wu Y, Zhong J, Sun X. Wang L, et al. Neurosci Lett. 2019 Aug 24;708:134338. doi: 10.1016/j.neulet.2019.134338. Epub 2019 Jun 18. Neurosci Lett. 2019. PMID: 31226363 - Elucidating the novel biomarker and therapeutic potentials of High-mobility group box 1 in Subarachnoid hemorrhage: A review.
Richard SA. Richard SA. AIMS Neurosci. 2019 Dec 2;6(4):316-332. doi: 10.3934/Neuroscience.2019.4.316. eCollection 2019. AIMS Neurosci. 2019. PMID: 32341986 Free PMC article. Review. - HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities.
Paudel YN, Angelopoulou E, Piperi C, Othman I, Shaikh MF. Paudel YN, et al. Int J Mol Sci. 2020 Jun 29;21(13):4609. doi: 10.3390/ijms21134609. Int J Mol Sci. 2020. PMID: 32610502 Free PMC article. Review.
Cited by
- Roles of HMGB1 on life-threatening traumatic brain injury and sequential peripheral organ damage.
Kawai C, Miyao M, Kotani H, Minami H, Abiru H, Tamaki K, Nishitani Y. Kawai C, et al. Sci Rep. 2024 Sep 13;14(1):21421. doi: 10.1038/s41598-024-72318-x. Sci Rep. 2024. PMID: 39271757 Free PMC article. - CDDO, an Anti-Inflammatory and Antioxidant Compound, Attenuates Vasospasm and Neuronal Cell Apoptosis in Rats Subjected to Experimental Subarachnoid Hemorrhage.
Winardi W, Lo YP, Tsai HP, Huang YH, Tseng TT, Chung CL. Winardi W, et al. Curr Issues Mol Biol. 2024 May 13;46(5):4688-4700. doi: 10.3390/cimb46050283. Curr Issues Mol Biol. 2024. PMID: 38785551 Free PMC article. - GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature.
Psochias F, Mavrovounis G, Stranjalis G, Kalamatianos T. Psochias F, et al. CNS Neurol Disord Drug Targets. 2024;23(11):1328-1344. doi: 10.2174/0118715273276472231116104549. CNS Neurol Disord Drug Targets. 2024. PMID: 38213168 - Systemic Inflammation after Aneurysmal Subarachnoid Hemorrhage.
Chai CZ, Ho UC, Kuo LT. Chai CZ, et al. Int J Mol Sci. 2023 Jun 30;24(13):10943. doi: 10.3390/ijms241310943. Int J Mol Sci. 2023. PMID: 37446118 Free PMC article. Review. - Integrative analysis of multi-omics data to identify three immune-related genes in the formation and progression of intracranial aneurysms.
Li S, Zhang Q, Huang Z, Chen F. Li S, et al. Inflamm Res. 2023 May;72(5):1001-1019. doi: 10.1007/s00011-023-01725-z. Epub 2023 Apr 4. Inflamm Res. 2023. PMID: 37014439
References
- Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660–4. - PubMed
- Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci. 2007;28:252–6. - PubMed
- Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28:1761–70. - PubMed
Grants and funding
- R01 HL078983/HL/NHLBI NIH HHS/United States
- P01 HL095488-02/HL/NHLBI NIH HHS/United States
- P01 HL095488/HL/NHLBI NIH HHS/United States
- P20 RR016435/RR/NCRR NIH HHS/United States
- R01 HL078983-05/HL/NHLBI NIH HHS/United States
- R01 HL078983-05S1/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous